Antigenic properties of phage displayed peptides comprising disulfide-bonded loop of the immunodominant region of HIV-1 gp41

Immunology Letters

Volumn 95, Issue 2, 2004, Pages 207-212

  Cano, Alberto ^a   Viveros, Monica ^b   Acero, Gonzalo ^a   Govezensky, Tzipe ^a   Munguia, Maria Elena ^a   Gonzalez, Eric ^a   Soto, Luis ^b   Gevorkian, Goar ^a   Manoutcharian, Karen ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Antigen; HIV 1 gp41 immunodominant region; Immunogen; Phage displayed peptides

Indexed keywords

ANTIRETROVIRUS AGENT; COAT PROTEIN; CYSTEINE; GLYCOPROTEIN GP 41; PEPTIDE; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISULFIDE BOND; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF;

BINDING, COMPETITIVE; DISULFIDES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV ANTIBODIES; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; IMMUNODOMINANT EPITOPES; MERCAPTOETHANOL; PEPTIDE LIBRARY; REDUCING AGENTS; SENSITIVITY AND SPECIFICITY;

EID: 4544227397     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.07.011     Document Type: Article

References (25)

1. D.C. Chan, and P.S. Kim HIV entry and its inhibition Cell 93 1998 681 684
2. R. Wyatt, and J. Sodroski The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens Science 280 1998 1884 1888
3. R.W. Doms, and J.P. Moore HIV-1 membrane fusion: targets of opportunity J. Cell Biol. 151 2000 F9 F14
4. D.M. Eckert, and P.S. Kim Mechanisms of viral membrane fusion and its inhibition Annu. Rev. Biochem. 70 2001 777 810
5. S.A. Gallo, C.M. Finnegan, M. Virad, Y. Raviv, A. Dimitrov, S.S. Rawat, A. Puri, S. Durell, and R. Blumenthal The HIV Env-mediated fusion reaction Biochim. Biophys. Acta 1614 2003 36 50
6. J.W. Gnann, P.L. Schwimmbeck, J.A. Nelson, A.B. Truax, and M.B.A. Oldstone Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus J. Infect. Dis. 156 1987 261 267
7. A. Narvanen, M. Korkolainen, J. Suni, J. Korpela, S. Kontio, P. Partanen, A. Vaheri, and M.L. Úntala Synthetic env gp41 peptide as a sensitive and specific diagnostic reagent in different stages of human immunodeficiency virus type 1 infection J. Med. Virol. 26 1988 111 118
8. P. Horal, B. Svennerholm, S. Jeansson, L. Rymo, W.W. Hall, and A. Vahlne Continuous epitopes of the human immunodeficiency type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates J. Virol. 65 1991 2718 2723
9. G. Gevorkian, C. Soler, M. Viveros, A. Padilla, T. Govezensky, and C. Larralde Serologic reactivity of a synthetic peptide from human immunodeficiency virus type 1 gp41 with sera from a mexican population Clin. Diagn. Lab. Immunol. 3 1996 651 653
10. G. Pancino, L. Camion, and P. Sonigo Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein J. Virol. 69 1995 2110 2118
11. W.J. Syu, W.R. Lee, B. Du, Q.C. Yu, M. Essex, and T.H. Lee Role of conserved gp41 cysteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivity J. Virol. 65 1991 6349 6352
12. D. Dedera, R.L. Gu, and L. Ratner Conserved cysteine residues in the human immunodeficiency virus type 1 transmembrane envelope protein are essential for precursor envelope cleavage J. Virol. 66 1992 1207 1209
13. S.A. Cumming, D.A. McPhee, W.J. Maskill, B.E. Kemp, R.R. Doherty, and I.D. Gust Use of conserved immunodominant epitope of HIV surface glycoprotein gp41 in the detection of early antibodies AIDS 4 1990 83 86
14. J.Y. Xu, M.K. Gorny, T. Palker, S. Karwowska, and S. Zolla-Pazner Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies J. Virol. 65 1991 4832 4838
15. G.P. Smith Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface Science 228 1985 1315 1317
16. N. Venkatesh, S.H. Im, M. Balass, S. Fuchs, and E. Katchalski-Katzir Prevention of passively transferred experimental autoimmune myasthenia gravis by a phage library-derived cyclic peptide Proc. Natl. Acad. Sci. U.S.A. 97 2000 761 766
17. K. Manoutcharian, G. Gevorkian, A. Cano, and J.C. Almagro Phage displayed biomolecules as preventive and therapeutic agents Curr. Pharm. Biotechnol. 2 2001 217 223
18. L.J. Matthews, R. Davis, and G.P. Smith Immunogenically fit subunit vaccine components via epitope discovery from natural peptide libraries J. Immunol. 169 2002 837 846
19. J. Sambbrook, E.F. Fritsch, and T. Maniatis Molecular cloning: a laboratory manual 2nd ed. 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
20. K. Manoutcharian, L.I. Terrazas, G. Gevorkian, G. Acero, P. Petrossian, M. Rodríguez, and T. Govezensky Phage-displayed T-cell epitope grafted into Immunoglobulin heavy-chain complementarity-determining regions: an effective vaccine design tested in murine cysticercosis Infect. Immun. 67 1999 4764 4770
21. K. Manoutcharian, J. Sotelo, E. Garcia, A. Cano, and G. Gevorkian Characterization of cerebrospinal fluid antibody specificities in neurocisticercosis using phage display peptide library Clin. Immunol. 91 1999 117 121
22. R.B. Merrifield Solid phase peptide synthesis I. The synthesis of a tetrapeptide J. Am. Chem. Soc. 85 1963 2149 2154
23. M.B. Zwick, J. Shen, and J.K. Scott Homodemeric peptides displayed by the major coat protein of filamentous phage J. Mol. Biol. 300 2000 307 320
24. J. Cotropia, K.E. Ugen, S. Kliks, K. Broliden, P.A. Broliden, J.A. Hoxie, V. Srikantan, W.V. Williams, and D.B. Weiner A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12 1996 221 232
25. M. Viveros, C. Dickey, J.P. Cotropia, G. Gevorkian, L. Larralde, K. Broliden, M. Levi, A. Burgess, C. Cao, D.B. Weiner, M.G. Agadjanyan, and K.E. Ugen Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region gp41 Virology 270 2000 135 145